Radiopharmaceuticals

"Radiopharmaceuticals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)

Descriptor ID	D019275
MeSH Number(s)	D27.505.259.843 D27.505.519.871 D27.720.470.410.650
Concept/Terms	Radiopharmaceuticals Radiopharmaceuticals

Below are MeSH descriptors whose meaning is more general than "Radiopharmaceuticals".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Diagnostic Uses of Chemicals [D27.505.259]
Radiopharmaceuticals [D27.505.259.843]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Radiopharmaceuticals [D27.505.519.871]
Specialty Uses of Chemicals [D27.720]
Laboratory Chemicals [D27.720.470]
Indicators and Reagents [D27.720.470.410]
Radiopharmaceuticals [D27.720.470.410.650]

Below are MeSH descriptors whose meaning is related to "Radiopharmaceuticals".

Below are MeSH descriptors whose meaning is more specific than "Radiopharmaceuticals".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Radiopharmaceuticals" by people in this website by year, and whether "Radiopharmaceuticals" was a major or minor topic of these publications.

Bar chart showing 106 publications over 26 distinct years, with a maximum of 10 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	2	3
1998	2	1	3
1999	2	0	2
2000	1	1	2
2001	0	1	1
2002	3	1	4
2003	3	7	10
2004	4	3	7
2005	0	2	2
2006	3	4	7
2007	1	7	8
2008	2	3	5
2009	3	5	8
2010	3	3	6
2011	2	4	6
2012	0	3	3
2013	3	2	5
2014	1	3	4
2015	2	1	3
2016	0	4	4
2017	1	5	6
2018	1	0	1
2019	1	1	2
2020	1	0	1
2021	1	1	2
2022	0	1	1

Below are the most recent publications written about "Radiopharmaceuticals" by people in Profiles.

Ninatti G, Sollini M, Bono B, Gozzi N, Fedorov D, Antunovic L, Gelardi F, Navarria P, Politi LS, Pessina F, Chiti A. Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas. Neuro Oncol. 2022 09 01; 24(9):1546-1556.

View in: PubMed
McIntosh LJ, Rosen MP, Mittal K, Whalen GF, Bathini VG, Ali T, Edmiston KL, Walsh WV, Gerber JM. Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination. Cancer Treat Rev. 2021 Jul; 98:102220.

View in: PubMed
McIntosh LJ, Bankier AA, Vijayaraghavan GR, Licho R, Rosen MP. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management. AJR Am J Roentgenol. 2021 10; 217(4):975-983.

View in: PubMed
Persky DO, Li H, Stephens DM, Park SI, Bartlett NL, Swinnen LJ, Barr PM, Winegarden JD, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, LeBlanc ML, Song JY, Fisher RI, Rimsza LM, Smith SM, Miller TP, Friedberg JW. Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001. J Clin Oncol. 2020 09 10; 38(26):3003-3011.

View in: PubMed
K?nik A, Auer B, De Beenhouwer J, Kalluri K, Zeraatkar N, Furenlid LR, King MA. Primary, scatter, and penetration characterizations of parallel-hole and pinhole collimators for I-123 SPECT. Phys Med Biol. 2019 12 13; 64(24):245001.

View in: PubMed
Pretorius PH, Ramon AJ, King MA, Konik A, Dahlberg ST, Parker MW, Botkin NF, Johnson KL, Yang Y, Wernick MN. Retrospective fractional dose reduction in Tc-99m cardiac perfusion SPECT/CT patients: A human and model observer study. J Nucl Cardiol. 2021 04; 28(2):624-637.

View in: PubMed
Alvi RM, Young BD, Shahab Z, Pan H, Winkler J, Herzog E, Miller EJ. Repeatability and Optimization of FDG?Positron Emission Tomography for?Evaluation of Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1284-1287.

View in: PubMed
Boucher JE, Sommers R. Targeted Therapy: New Radiolabeled Somatostatin Analogs to Treat Gastroenteropancreatic Neuroendocrine Tumors. Clin J Oncol Nurs. 2018 10 01; 22(5):565-568.

View in: PubMed
Bencardino JT, Stone TJ, Roberts CC, Appel M, Baccei SJ, Cassidy RC, Chang EY, Fox MG, Greenspan BS, Gyftopoulos S, Hochman MG, Jacobson JA, Mintz DN, Mlady GW, Newman JS, Rosenberg ZS, Shah NA, Small KM, Weissman BN. ACR Appropriateness Criteria? Stress (Fatigue/Insufficiency) Fracture, Including Sacrum,?Excluding Other Vertebrae. J Am Coll Radiol. 2017 May; 14(5S):S293-S306.

View in: PubMed
Gauguet JM, Pace-Emerson T, Grant FD, Shusterman S, DuBois SG, Frazier AL, Voss SD. Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma. Pediatr Blood Cancer. 2017 Nov; 64(11).

View in: PubMed

People

Explore

Similar Concepts

Top Journals